Gilead Sciences, Inc. (FRA:GIS)
104.88
+0.20 (0.19%)
At close: Oct 23, 2025
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,396,412
Profits / Employee
€305,330
Market Cap
129.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17,600 | -400 | -2.22% |
| Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
| Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
| Dec 31, 2021 | 14,400 | 800 | 5.88% |
| Dec 31, 2020 | 13,600 | 1,800 | 15.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
| Siemens Healthineers AG | 72,000 |
Gilead Sciences News
- 17 hours ago - TD Cowen Raises Price Target for Gilead Sciences (GILD) to $125 | GILD Stock News - GuruFocus
- 23 hours ago - Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta - Business Wire
- 1 day ago - CVS (CVS) Delays Adding Gilead's Yeztugo Over Pricing Concerns - GuruFocus
- 1 day ago - CVS reportedly cites pricing concerns in excluding coverage for Gilead’s new HIV drug - Seeking Alpha
- 1 day ago - Gilead Sciences (GILD) Halts Phase 1 HIV Treatment Trial - GuruFocus
- 1 day ago - Gilead Sciences (GILD) Halts Phase 1 Study for HIV Treatment - GuruFocus
- 1 day ago - Gilead discontinues early-stage trial for long-acting injectable for HIV - Seeking Alpha
- 2 days ago - Final Trade: F, HAL, MA, GILD - CNBC